Baricitinib Versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to Background Methotrexate Therapy: Results of a Phase 3 Study

被引：0
|
作者：
Taylor, Peter C. [1 ]
Keystone, Edward C. [2 ,3 ]
van der Heijde, D. [4 ]
Tanaka, Yoshiya [5 ]
Ishii, Taeko [6 ]
Emoto, Kahaku [6 ]
Yang, Lili [6 ]
Arora, Vipin [6 ]
Gaich, Carol L. [6 ]
Rooney, Terence [6 ]
Schlichting, Douglas E. [6 ]
Macias, William [6 ]
de Bono, Stephanie [6 ]
Weinblatt, Michael E. [7 ]
机构：
[1] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Sci, Kennedy Inst Rheumatol, Oxford, England
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Toronto, Mt Sinai Hosp, Rebecca MacDonald Ctr, Toronto, ON M5G 1X5, Canada
[4] Leiden Univ, Med Ctr, Leiden, Netherlands
[5] Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Japan
[6] Eli Lilly & Co, Indianapolis, IN 46285 USA
[7] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2L
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
    Kaeley, Gurjit S.
    Nishio, Midori J.
    Goyal, Janak R.
    MacCarter, Daryl K.
    Wells, Alvin F.
    Chen, Su
    Kupper, Hartmut
    Kalabic, Jasmina
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68 (11) : 2584 - 2592
  • [42] BARICITINIB VERSUS ADALIMUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: ANALYSIS OF PATIENTS ACHIEVING A MODERATE EULAR RESPONSE AT WEEK 4
    Kvien, T. K.
    van Riel, P.
    Rubbert-Roth, A.
    Blanco, R.
    Liu-Leage, S. S.
    Larsson, E.
    Lund, H.
    Lopez-Romero, P.
    Zaremba-Pechmann, L.
    Emery, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 794 - 795
  • [43] Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial
    Taylor, Peter C.
    Lee, Yvonne C.
    Fleischmann, Roy
    Takeuchi, Tsutomu
    Perkins, Elizabeth L.
    Fautrel, Bruno
    Zhu, Baojin
    Quebe, Amanda K.
    Gaich, Carol L.
    Zhang, Xiang
    Dickson, Christina L.
    Schlichting, Douglas E.
    Patel, Himanshu
    Durand, Frederick
    Emery, Paul
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (06)
  • [44] PATIENT-REPORTED OUTCOMES FROM A PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITORS
    Smolen, J. S.
    Kremer, J.
    Gaich, C.
    DeLozier, A. M.
    Schlichting, D.
    Xie, L.
    Genovese, M. C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 785 - 786
  • [45] Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics
    Kremer, Joel M.
    Schiff, Michael
    Muram, David
    Zhong, Jinglin
    Alam, Jahangir
    Genovese, Mark C.
    [J]. RMD OPEN, 2018, 4 (01):
  • [46] SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE
    Nash, Peter
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Fleischmann, Roy
    [J]. INTERNAL MEDICINE JOURNAL, 2021, 51 : 46 - 47
  • [47] Sustainability of Response Between Upadacitinib and Adalimumab Among Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
    Nash, Peter
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [48] A Twelve-Week Exploratory Phase II Trial of GLPG0259 Versus Placebo in Patients with Active Rheumatoid Arthritis and Inadequate Response to Methotrexate.
    Westhovens, Rene
    De Keyser, Filip
    Rekalov, Dmitro
    Nasonov, Evgeny L.
    Beetens, Johan
    Van der Aa, Annegret
    Wigerinck, Piet
    Namour, Florence
    Vanhoutte, Frederic
    Durez, Patrick
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S874 - S875
  • [49] SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE
    Nash, P.
    Kavanaugh, A.
    Buch, M. H.
    Combe, B.
    Bessette, L.
    Song, I. H.
    Song, Y.
    Suboticki, J.
    Fleischmann, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 643 - 644
  • [50] UPADACITINIB AS MONOTHERAPY: A PHASE 3 RANDOMIZED CONTROLLED DOUBLE-BLIND STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE
    Smolen, J. S.
    Cohen, S.
    Emery, P.
    Rigby, W.
    Tanaka, Y.
    Zhang, Y.
    Friedman, A.
    Othman, A. A.
    Camp, H. S.
    Pangan, A. L.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S52 - S52
12345